Call

Call

Carl Bryce of Brookfield Plc to speak at Big Call: ESG Investors Forum


Brookfield Investment Funds Plc is pleased to announce that Carl Bryce, Director of Finance, will attend and speak at the Big Call: ESG Investors Forum on Wed, 25 November 2020 at 1 Moorgate Place, London EC2R 6EA, United Kingdom.

This event will explore the issues currently facing investors and the factors that will continue to drive the green revolution. This half day event is complimentary and exclusively aimed at:

Multi-managers
DFMs
Pension funds / Endowments
Multi-family offices
Private banks
Insurance companies
Private client wealth managers
Portfolio managers and strategists
Please keep an eye out for our updated agenda.

Inherently alternative investments are generally more complicated than traditional investments, which dictates that the skill set required to manage them correctly is not always found within the arena of traditional investments. On this note, when choosing an alternative investment fund, Brookfield Investment Funds PLC looks to identify those that have shown particular understanding and expertise within the underlying asset arena.

The Exchange Building
George’s Dock,
International Financial Services Centre,
Dublin 1, D01 P2V6, Ireland
+353 1 691 7462
info@brookfieldinvestmentfundsplc.net

Exchange Tower
1 Harbour Exchange Square,
London, E14 9GE, UK
+44 207 660 1459

Source link

Medi-Immune Ltd – ProtectivAir® Call to Manufacture


Medi-Immune, Ltd have today (31-04-2020) announced an urgent call for proposals to create global partnerships and alliances to facilitate the rapid manufacture and deployment of their ProtectivAir® compact, wearable, breathing (PPE) device which will protect front-line healthcare staff and those working in biologically compromised environments.

Medi-Immune is fully confident, based upon previous tests and established science that ProtectivAir® will prove effective in protecting users from the COVID-19 virus. This has triggered a global positive response that has confirmed an overwhelming demand to bring ProtectivAir® into production and deployment as soon as possible. Initial estimates, based upon responses to date, indicate an immediate demand for ProtectivAir® in excess of 2,000,000 units.

Medi-Immune believes that with the right global partnership ProtectivAir®, could be in production in weeks, providing protection and saving lives long before production and deployment of a vaccine. To indicate your organisation’s interest in assisting Medi-Immune realize this potential and help in the global fight against the COVID-19 pandemic please contact Medi-Immune by visiting www.medi-immune.com for further details or contact directly at:

Medi-Immune believes the reasons behind the overwhelming market response to ProtectivAir® can be summarised as follows:
• Disables airborne pathogens before they are inhaled
• Immediately protects the user from infection
• Does not use a filter. This allied with an optional, small positive air pressure generated by the device and tailored to best suit each user type/application environment, provides far better protection from leakage than existing mask systems.
• It is mask manufacturer independent, standard masks can be attached and designed to best suit multiple user type/application environments
• Superior operator protection over N95/99 and FFP3 face masks as well as much improved breathability and ease of use for the wearer. There is no requirement for fit testing or fit test training. ProtectivAir® is completely reusable, internally self-sterilising (the outside can be surface decontaminated) and does not suffer from reduced efficacy over time (like conventional face masks).
• Public Health England – at their Porton Down laboratories, have validated test results – confirming protection.

Infectious diseases emerge at a frequency of one every 8 months of which a proportion are pathogens transmitted as aerosols. Emerging respiratory diseases do and will continue to cause havoc within the world’s population, as is happening now with the ever worsening COVID-19 pandemic. The technology utilized by ProtectivAir®’ is by design pathogen independent, this unique innovation along with a prolonged shelf-life, means it can be stockpiled for later use and represents an investment against future outbreaks in addition to the current COVID-19 pandemic.

ProtectivAir® is an all-British invention, patented internationally, and represents a paradigm shift in respiratory protection. UVc has long been known and used as a way to sterilise surfaces and instruments but this novel application harnesses this technology to sterilise breathing air to protect users/wearers of the device.

Source link

WildJar Releases Microsoft Search Advertising Integration to Enhance Call Attribution


SYDNEY, AU – WildJar, a leading global communications software as a service platform, announces that it has released an advanced integration with Microsoft Search Advertising which allows marketers to capture rich call attribution data from Microsoft Ads and use it to provide further insights into consumer purchasing behaviour.

WildJar now has the ability to send web and conversion data from phone calls directly into Microsoft Ads. This integration enhances campaign performance by automatically connecting conversions back to the specific search keywords, ads or campaigns that customers interacted with during their search, allowing for a detailed picture of a customer’s purchasing behaviour.

We are growth focused and always striving to deliver cutting edge voice and SMS solutions for our clients,” states James O’Neill, Co-Founder and CEO of WildJar. “Our new Microsoft Search Advertising integration is yet another example where we have listened to our clients’ requests and reinforces WildJar as one of the fastest growing global call intelligence platforms. It has been fantastic working with the Microsoft team and I am happy to say the integration is now live and available.”

Microsoft Search Advertising market share continues to grow globally, with over one third PC search market share in the US, 23% in the United Kingdom, 16% in France and nearly 16% in Australia. Microsoft’s careful selection of key partnerships such as The Wall Street Journal, Yahoo, CBS Interactive and many more, helps marketers increase their digital footprint whilst bringing high-quality traffic and increased clicks to their marketing strategy.

“We are delighted to see that WildJar have completed an integration to our API. For Microsoft Advertising customers that rely on calls from a performance standpoint, this will enhance their ability to measure performance on our platform, and we are excited to see the positive impact that will result from this integration” said Paul Korber, Director of Partner Development AUNZ, Microsoft Advertising.

To learn more about the WildJar integration with Microsoft Search Advertising, visit WildJar.com or call 1300 317 533

About WildJar

WildJar helps businesses become wildly successful by providing cutting edge voice and SMS solutions. Founded in 2016, WildJar has helped more than 4,000 companies worldwide drive revenue and connect their customer’s journey online to their purchasing behaviour offline. Finally, businesses and marketers have complete attribution and analytics to measure call outcomes and ROI. With WildJar’s Voice Platform, businesses get granular campaign attribution to understand why customers are calling, real-time intelligence about who’s calling and analyse what’s being said during conversations to improve outcomes.

Source link